Stephane Bancel serves as Executive at BG Medicine, Inc., where they oversee executive responsibilities. Since joining the company, Stephane Bancel has executed 1571 insider transactions totaling $1.2B, demonstrating a bearish approach to their equity position. Their most recent transaction on Apr 13, 2023 involved selling 30,456 shares valued at $4.9M.
Stephane Bancel currently holds 6,181,970 shares of BG Medicine, Inc. (BGMD), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Stephane Bancel has been a net seller of BGMD stock. They have purchased $226.2K and sold $1.2B worth of shares.
Stephane Bancel's most recent insider trade was on Apr 13, 2023, when they sold 30,456 shares at $160.63 per share.
Get notified when new Form 4 filings are submitted
| $0.99 |
| Planned |
| Apr 13, 2023 | MRNA | $16.2K | Sale | 100 | $161.98 | Planned |
| Apr 12, 2023 | MRNA | $2.6M | Sale | 16,650 | $156.69 | Planned |
| Apr 12, 2023 | MRNA | $39.6K | Option Exercise | 40,000 | $0.99 | Planned |
| Apr 12, 2023 | MRNA | $2.0M | Sale | 12,634 | $155.67 | Planned |
| Apr 12, 2023 | MRNA | $377.7K | Sale | 2,382 | $158.56 | Planned |
| Apr 12, 2023 | MRNA | $1.3M | Sale | 8,334 | $157.67 | Planned |
| Apr 6, 2023 | MRNA | $39.6K | Option Exercise | 40,000 | $0.99 | Planned |
| Apr 6, 2023 | MRNA | $424.0K | Sale | 2,739 | $154.79 | Planned |
| Apr 6, 2023 | MRNA | $1.2M | Sale | 7,602 | $155.58 | Planned |
| Apr 6, 2023 | MRNA | $188.4K | Sale | 1,200 | $157.00 | Planned |
| Apr 6, 2023 | MRNA | $4.0M | Sale | 25,343 | $158.19 | Planned |
| Apr 6, 2023 | MRNA | $494.9K | Sale | 3,116 | $158.81 | Planned |
| Apr 5, 2023 | MRNA | $39.6K | Option Exercise | 40,000 | $0.99 | Planned |
| Apr 5, 2023 | MRNA | $1.0M | Sale | 6,666 | $152.74 | Planned |
| Apr 5, 2023 | MRNA | $450.8K | Sale | 2,934 | $153.66 | Planned |
| Apr 5, 2023 | MRNA | $3.5M | Sale | 22,533 | $155.01 | Planned |
| Apr 5, 2023 | MRNA | $17.7K | Sale | 113 | $156.50 | Planned |
| Apr 5, 2023 | MRNA | $1.2M | Sale | 7,754 | $155.54 | Planned |
| Mar 30, 2023 | MRNA | $39.6K | Option Exercise | 40,000 | $0.99 | Discretionary |
| Mar 30, 2023 | MRNA | $2.0M | Sale | 13,900 | $147.13 | Discretionary |
| Mar 30, 2023 | MRNA | $441.6K | Sale | 2,979 | $148.24 | Discretionary |
| Mar 30, 2023 | MRNA | $2.4M | Sale | 15,965 | $149.39 | Discretionary |
| Mar 30, 2023 | MRNA | $1.1M | Sale | 7,156 | $149.99 | Discretionary |
| Mar 29, 2023 | MRNA | $39.6K | Option Exercise | 40,000 | $0.99 | Discretionary |
| Mar 29, 2023 | MRNA | $52.6K | Sale | 351 | $149.72 | Discretionary |
| Mar 29, 2023 | MRNA | $1.2M | Sale | 8,300 | $148.83 | Discretionary |
| Mar 29, 2023 | MRNA | $4.6M | Sale | 31,349 | $148.21 | Discretionary |
| Mar 23, 2023 | MRNA | $39.6K | Option Exercise | 40,000 | $0.99 | Discretionary |